Hemodialysis Complication
Conditions
Keywords
Hemodialysis, ice massage, pain, hematoma, ecchymosis, patient satisfaction
Brief summary
The research was planned to measure pain, ecchymosis, hematoma and patient satisfaction with ice massage applied to the fistula before the arteriovenous fistula procedure in hemodialysis patients. Patients who agree to participate in the study will be given ice massage before the procedure and the relevant parameters will be measured.
Detailed description
Chronic renal failure is a condition that causes irreversible damage to kidney functions and prevents the excretion of metabolic wastes through urine. In the treatment of the disease; renal replacement therapies and kidney transplant options are available. The most commonly used treatment in end-stage renal failure patients is hemodialysis. Hemodialysis is performed through catheters and fistula channels. Patients receiving hemodialysis treatment through fistula are connected to the dialysis device. For this procedure, an injection occurs 2 or 3 times a week. It is a distressing situation for patients that needle insertion is painful during the procedure and that conditions such as ecchymosis and hematoma frequently occur afterwards. In this study, cold application was planned in a pre-test post-test design to evaluate pain, ecchymosis, hematoma and patient satisfaction. Volunteer participants who receive hemodialysis treatment through fistula will receive an ice massage for an average of 3-5 minutes on the fistula area where the needle will be inserted before the procedure.
Interventions
OTHERice massage group
Measurement surveys will be applied to obtain pre-test data from hemodialysis patients who meet the research criteria. After the preliminary test data are obtained, ice cubes prepared by the researchers before the needle insertion into the arteriovenous fistula for the hemodialysis procedure will be wrapped in a thin sponge and an ice massage will be applied to the needle insertion area of the patient in a direction that will not disrupt the circulation. This process will take approximately 3-5 minutes or the massage will be terminated when the patient feels drowsiness. In the next stage, the patient will undergo needle intervention for hemodialysis. At the end of this stage, the patient's pain will be evaluated. Patients will be re-evaluated at 24, 48 and 72 hours for ecchymosis and hematoma and relevant measurements will be provided.
Sponsors
Erzurum Technical University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
The research is quasi-experimental and relationship-seeking in a pretest-posttest format.
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Conscious and oriented * Communicable, * Those who are 18 years or older, * Hemodialysis treatment is applied via arteriovenous fistula, * There are no signs of infection such as redness, swelling, or open wound in the area where the procedure will be performed, * Patient: International Normalized Ratio: 2-3, Activated Partial Thromboplastin Time: 27-45 sec. Prothrombin Time: 11-16 sec. Thrombocyte: 125-350 m3 * Can tolerate the application, * 10 minutes before starting Hemodialysis treatment. vissual analog scale pain score was evaluated beforehand and vissual analog scale was ≥4. * Patients who agree to participate in the study verbally and in writing will be included in the research.
Exclusion criteria
* Unconscious, * Unable to communicate, * Those who are under 18 years of age, * Hemodialysis treatment is not applied via arteriovenous fistula, * If there is any sign of infection such as redness, swelling, open wound in the area where cannulation will be performed, * 10 minutes before starting hemodialysis treatment. vissual analog scale pain score was evaluated beforehand and vissual analog scale ≤ 4 * Using any painkillers before the procedure on the same day, * Patient: International Normalized Ratio: 2-3, Activated Partial Thromboplastin Time: 27-45 sec. Prothrombin Time: 11-16 sec. Thrombocyte: above 125-350 m3, prone to bleeding, * Patients who cannot tolerate the application or do not want to participate in the study voluntarily will not be included in the research.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain score | 3 days | Vissual analog scale: The scale is rated between 0 points and 10 points. 0 indicates that the patient has no pain, and 10 indicates that the patient has unbearable pain. Patients report their pain status on a scale of 0 to 10 points. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ecchymosis degree | 3 days | The area of the ecchymosis will be calculated in square millimeters with polyethylene millimetric plastic film (opsite flexigrid). |
| Hematoma degree | 3 days | The area of the hematoma will be calculated in square millimeters with polyethylene millimetric plastic film (opsite flexigrid). |
| Patient satisfaction score | 3 days | Numerical Satisfaction Scale: The scale is rated between 0 points and 10 points. 0 indicates that the patient is very dissatisfied, and 10 indicates that the patient is very satisfied. Patients report their satisfaction between 0 and 10 points. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactErcan Bakır, PhD
Backup ContactErcan Bakır, PhD
Outcome results
None listed